Hair Cloning in Phase II. Clinical Testing under a Single Umbrella

Hair multiplication, also known as hair cloning, is amongst the most promising future treatments for hair loss that are being currently examined. The main focus of this method is to overcome the shortage of donor hair, which happens to be the main weakness of hair transplantation. The number of donor hair and so the amount of hair that can be used is limited as hair transplantation simply consists in moving hair from the back and from the sides of one’s scalp to the balding area. The aim of hair multiplication is to grow new hair follicles in vitro and then inject these newly grown cells into the balding area where they would induce new hair growth.

The two frontrunners in this research until recently were Bosley, the largest chain of hair transplant clinics in the US and a UK based skin regeneration research firm Intercytex. However, Intercytex got in serious financial difficulties due to its poor financial performance in 2008, the global economic crisis and a failure of its leading product Cyzact so that it was put up for sale. As expected, Bosley got involved through its subsidiary Aderans Research Institute and took over the Intercytex’s research unit involved in hair regeneration so that now Bosley now has got two units involved in research into hair cloning and both of them are in the Phase II. clinical testing. Bosley has thus become the world leader in hair regeneration research.